COVID-19 vaccination in adults with inflammatory bowel disease

Patients with inflammatory bowel disease (IBD) are not at increased risk of SARS-CoV-2 infection compared to the general population, and most are not at increased risk for severe disease. COVID-19 is nonetheless common, and vaccination is critical. Four safe and efficacious vaccines are now availabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutz, Megan, Lazarus, Sarah, Caldera, Freddy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
The Impact of COVID-19 in Gastrointestinal Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203854/
https://www.ncbi.nlm.nih.gov/pubmed/37234702
http://dx.doi.org/10.1177/17562848231173130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203854/
https://www.ncbi.nlm.nih.gov/pubmed/37234702
http://dx.doi.org/10.1177/17562848231173130

Ejemplares similares